Probiotic yeasts as next-generation biotherapeutics for Type 2 diabetes mellitus: From gut microbiota modulation to molecular signaling
Journal of Advances in Microbiology Research · 01.06.2026 · 7 (6) · 21-30
DOI: 10.22271/micro.2026.v7.i6a.369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Advances in Microbiology Research, online erschienen am 01.06.2026. Verfasst von Nayan Rishi und 3 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rishi, N., Mathur, H. K., Arya, J., & Rana, S. (2026). Probiotic yeasts as next-generation biotherapeutics for Type 2 diabetes mellitus: From gut microbiota modulation to molecular signaling. Journal of Advances in Microbiology Research, 7(6), 21-30. https://doi.org/10.22271/micro.2026.v7.i6a.369
Vancouver
Rishi N, Mathur HK, Arya J, Rana S. Probiotic yeasts as next-generation biotherapeutics for Type 2 diabetes mellitus: From gut microbiota modulation to molecular signaling. Journal of Advances in Microbiology Research. 2026;7(6):21-30. doi:10.22271/micro.2026.v7.i6a.369
BibTeX
@article{Rishi2026,
author = {Rishi, Nayan and Mathur, Harsh Kumar and Arya, Jitendra and Rana, Sagar},
title = {Probiotic yeasts as next-generation biotherapeutics for Type 2 diabetes mellitus: From gut microbiota modulation to molecular signaling},
journal = {Journal of Advances in Microbiology Research},
year = {2026},
volume = {7},
number = {6},
pages = {21--30},
doi = {10.22271/micro.2026.v7.i6a.369}
}
EUVIMED